STOCK TITAN

Ametek, Inc. (AME) Financials

AME
Trailing 12 months to June 30, 2026
Revenue $7.9B +12.7% YoY
Net Income $1.6B +9.6% YoY
EPS (Diluted) $6.84 +10.1% YoY
Free Cash Flow $1.8B +8.4% YoY
Market Cap $57.8B as of Oct 3, 2026
Price / Sales 7.3x on $7.9B revenue, trailing 12 months to June 30, 2026
Price / Earnings 36.6x on $1.6B net income, trailing 12 months to June 30, 2026
Price / Book 5.1x on $11.3B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AME SEC filings page.

Ametek, Inc. (AME) reported $7.9B in revenue over the twelve months to Jun 30, 2026, up 12.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AME FY2025

AMETEK grows through expanding margins and cash generation, while balance-sheet growth remains increasingly tied to goodwill.

FY2025 earnings quality softened slightly: revenue and net income increased, but free cash flow declined from $1.70B in FY2024 to $1.67B. That divergence, alongside a lower free-cash-flow margin of 22.6%, suggests incremental accounting profit converted to cash less efficiently than the prior year.

Operating leverage is visible across the period: revenue rose from $5.55B in FY2021 to $7.40B in FY2025, while operating margin widened from 23.6% to 25.8%. Costs therefore did not rise proportionally with sales, allowing more revenue to reach operating income.

The balance sheet is conservatively financed but goodwill-heavy: debt-to-equity fell from 0.3x in FY2021 to 0.1x in FY2025, even as goodwill reached $7.17B, approximately 44.6% of total assets. Meanwhile, the current ratio slipped to 1.1x, indicating that short-term asset coverage narrowed despite lower leverage.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 69 / 100
Financial Health Score 69/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Ametek, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
95

Ametek, Inc. has an operating margin of 25.8%, meaning the company retains $26 of operating profit per $100 of revenue. This strong profitability earns a score of 95/100, reflecting efficient cost management and pricing power. This is up from 25.6% the prior year.

Growth
54

Ametek, Inc.'s revenue grew 6.6% year-over-year to $7.4B, a solid pace of expansion. This earns a growth score of 54/100.

Leverage
71

Ametek, Inc. carries a low D/E ratio of 0.10, meaning only $0.10 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 71/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
22

Ametek, Inc.'s current ratio of 1.06 is below the typical benchmark, resulting in a score of 22/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
89

Ametek, Inc. converts 22.6% of revenue into free cash flow ($1.7B). This strong cash generation earns a score of 89/100.

Returns
85

Ametek, Inc. earns a strong 13.9% return on equity (ROE), meaning it generates $14 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 85/100. This is down from 14.2% the prior year.

Altman Z-Score Safe
8.31

Ametek, Inc. scores 8.31, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($57.8B) relative to total liabilities ($5.4B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
6/9

Ametek, Inc. passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
1.22x

For every $1 of reported earnings, Ametek, Inc. generates $1.22 in operating cash flow ($1.8B OCF vs $1.5B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
23.51x

Ametek, Inc. earns $23.51 in operating income for every $1 of interest expense ($1.9B vs $81.3M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$2.0B
YoY+15.0%
QoQ+6.0%
5Y CAGR+8.1%
10Y CAGR+7.7%

Ametek, Inc. generated $2.0B in revenue in Q2 2026. This represents an increase of 15.0% from the same quarter a year earlier. Against the prior quarter it is up 6.0%.

EBITDA
$634.1M
YoY+11.4%
QoQ+2.2%
5Y CAGR+10.1%
10Y CAGR+10.3%

Ametek, Inc.'s EBITDA was $634.1M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 11.4% from the same quarter a year earlier. Against the prior quarter it is up 2.2%.

Net Income
$406.9M
YoY+13.5%
QoQ+1.9%
5Y CAGR+11.9%
10Y CAGR+11.4%

Ametek, Inc. reported $406.9M in net income in Q2 2026. This represents an increase of 13.5% from the same quarter a year earlier. Against the prior quarter it is up 1.9%.

EPS (Diluted)
$1.77
YoY+14.2%
QoQ+1.7%
5Y CAGR+12.1%
10Y CAGR+11.6%

Ametek, Inc. earned $1.77 per diluted share (EPS) in Q2 2026. This represents an increase of 14.2% from the same quarter a year earlier. Against the prior quarter it is up 1.7%.

Cash & Balance Sheet

Free Cash Flow
$451.7M
YoY+36.9%
QoQ+6.0%
5Y CAGR+11.4%
10Y CAGR+10.0%

Ametek, Inc. generated $451.7M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 36.9% from the same quarter a year earlier. Against the prior quarter it is up 6.0%.

Cash & Debt
$495.4M
YoY-20.1%
QoQ+2.9%
5Y CAGR+4.9%
10Y CAGR+0.8%

Ametek, Inc. held $495.4M in cash against $1.1B in long-term debt as of Q2 2026.

Dividends Per Share
$0.34
YoY+9.7%
QoQ0.0%

Ametek, Inc. paid $0.34 per share in dividends in Q2 2026. This represents an increase of 9.7% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
229M
YoY-0.7%
QoQ0.0%
5Y CAGR-0.2%
10Y CAGR-0.1%

Ametek, Inc. had 229M shares outstanding in Q2 2026. This represents a decrease of 0.7% from the same quarter a year earlier. It is unchanged from the prior quarter.

Margins & Returns

Gross Margin
35.9%
YoY+0.2pp
QoQ-1.3pp
5Y change+1.8pp

Ametek, Inc.'s gross margin was 35.9% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.3 percentage points.

Operating Margin
25.8%
YoY-0.1pp
QoQ-0.9pp
5Y change+3.0pp
10Y change+3.4pp

Ametek, Inc.'s operating margin was 25.8% in Q2 2026, reflecting core business profitability. This is down 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.9 percentage points.

Net Margin
19.9%
YoY-0.3pp
QoQ-0.8pp
5Y change+3.2pp
10Y change+5.8pp

Ametek, Inc.'s net profit margin was 19.9% in Q2 2026, showing the share of revenue converted to profit. This is down 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.

Return on Equity
3.6%
YoY+0.2pp
QoQ-0.1pp
5Y change0.0pp
10Y change-0.5pp

Ametek, Inc.'s ROE was 3.6% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.

Capital Allocation

Share Buybacks
$165K
YoY+48.6%
QoQ-99.4%
5Y CAGR-49.2%
10Y CAGR-37.7%

Ametek, Inc. spent $165K on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 48.6% from the same quarter a year earlier. Against the prior quarter it is down 99.4%.

Capital Expenditures
$32.0M
YoY+9.4%
QoQ+25.7%
5Y CAGR+6.4%
10Y CAGR+8.5%

Ametek, Inc. invested $32.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 9.4% from the same quarter a year earlier. Against the prior quarter it is up 25.7%.

R&D Spending

Not reported for Q2 2026.

AME Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AME quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$2.0B+15.0%$1.9B+11.3%$2.0B+13.4%$1.9B+10.8%$1.8B+2.5%$1.7B-0.2%$1.8B+1.8%$1.7B+5.3%
Cost of Revenue$1.3B+14.6%$1.2B+9.4%$1.3B+14.4%$1.2B+10.4%$1.1B+2.9%$1.1B-3.3%$1.1B+0.1%$1.1B+7.0%
Gross Profit$735.0M+15.6%$717.6M+14.8%$720.4M+11.7%$686.1M+11.4%$635.9M+1.8%$625.0M+5.7%$644.7M+4.8%$615.8M+2.3%
SG&A Expenses$206.8M+18.7%$202.6M+19.1%$214.9M+22.3%$197.8M+16.4%$174.3M-1.5%$170.2M-2.4%$175.8M+3.4%$170.0M+3.8%
Operating Income$528.2M+14.4%$514.9M+13.2%$505.5M+7.8%$488.4M+9.5%$461.6M+3.2%$454.8M+9.0%$469.0M+5.4%$445.9M+1.8%
EBITDA$634.1M+11.4%$620.4M+10.6%$611.1M+8.2%$591.5M+10.3%$569.3M+4.2%$561.2M+8.9%$564.9M+5.2%$536.2M+3.1%
Interest Expense$30.1M+78.6%$20.9M+10.1%$22.9M+4.0%$22.5M-10.4%$16.9M-44.9%$19.0M-46.1%$22.0M-8.8%$25.1M+36.6%
Income Tax$85.5M+2.0%$93.6M+13.5%$75.4M+32.0%$76.5M-2.6%$83.8M+5.6%$82.5M+17.2%$57.1M-22.9%$78.6M+7.5%
Net Income$406.9M+13.5%$399.4M+13.5%$398.6M+2.9%$371.4M+9.2%$358.4M+6.1%$351.8M+13.1%$387.3M+12.9%$340.2M0.0%
EPS (Basic)$1.78+14.8%$1.74+14.5%$1.73+3.6%$1.61+9.5%$1.55+6.2%$1.52+12.6%$1.67+12.1%$1.47-0.7%
EPS (Diluted)$1.77+14.2%$1.74+14.5%$1.73+3.6%$1.60+8.8%$1.55+6.9%$1.52+13.4%$1.67+12.8%$1.470.0%
Diluted Shares (Avg)230M-0.7%230M-0.7%N/A232M-0.2%231M-0.4%232M-0.2%N/A232M+0.2%

Not reported in any period shown, so not listed: R&D Expenses.

AME Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AME quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$16.6B+8.7%$16.3B+9.6%$16.1B+9.8%$16.2B+9.6%$15.3B+3.2%$14.9B+0.1%$14.6B-2.6%$14.8B+12.8%
Current Assets$3.2B+5.7%$3.1B+13.6%$3.0B+16.0%$3.1B+12.0%$3.1B+10.3%$2.8B-0.5%$2.6B-7.8%$2.7B-12.3%
Cash & Equivalents$495.4M-20.1%$481.3M+20.6%$458.0M+22.4%$439.2M+10.8%$619.7M+56.3%$399.0M+6.8%$374.0M-8.7%$396.3M-52.9%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$1.2B+7.6%$1.1B+6.9%$1.1B+8.3%$1.2B+6.3%$1.1B+0.8%$1.1B-5.1%$1.0B-9.8%$1.1B-0.3%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$7.4B+10.3%$7.3B+9.6%$7.2B+9.4%$7.2B+9.7%$6.7B+4.2%$6.6B+3.0%$6.6B+1.7%$6.6B+19.6%
Total Liabilities$5.3B+9.3%$5.4B+9.8%$5.4B+9.3%$5.7B+8.4%$4.9B-12.0%$4.9B-16.8%$5.0B-20.9%$5.2B+9.8%
Current Liabilities$2.7B+42.3%$2.8B+40.4%$2.8B+35.5%$2.6B+34.7%$1.9B-15.2%$2.0B-21.6%$2.1B-27.2%$2.0B+17.5%
Non-Current Liabilities$2.7B-11.1%$2.6B-10.5%$2.6B-9.8%$3.0B-7.5%$3.0B-9.9%$2.9B-13.2%$2.9B-15.6%$3.3B+5.6%
Long-Term Debt$1.1B-31.2%$1.1B-27.2%$1.1B-24.6%$1.4B-19.2%$1.5B-15.9%$1.5B-22.3%$1.4B-24.8%$1.8B-4.9%
Total Equity$11.3B+8.4%$10.9B+9.5%$10.6B+10.1%$10.5B+10.2%$10.4B+12.3%$10.0B+11.2%$9.7B+10.6%$9.6B+14.5%
Retained Earnings$12.9B+11.0%$12.6B+10.9%$12.3B+10.8%$11.9B+11.1%$11.6B+11.1%$11.3B+11.3%$11.1B+11.2%$10.7B+11.2%

Not reported in any period shown, so not listed: Accounts Receivable.

AME Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AME quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$483.7M+34.7%$451.5M+8.1%$584.3M+6.2%$440.9M-9.5%$359.1M-5.9%$417.5M+1.8%$550.0M+1.7%$487.2M+3.0%
Depreciation & Amortization$105.9M-1.6%$105.5M-0.8%$105.7M+10.2%$103.1M+14.1%$107.7M+9.1%$106.4M+8.5%$95.9M+4.3%$90.4M+10.5%
Stock-Based Compensation$13.9M+8.1%$9.7M+2.6%N/A$12.9M+1.4%$12.8M-2.8%$9.5M+5.8%N/A$12.7M-1.3%
Capital Expenditures$32.0M+9.4%$25.5M+10.4%$57.0M+10.2%$20.9M-20.4%$29.3M+36.7%$23.1M-16.6%$51.7M-13.4%$26.3M-8.3%
Free Cash Flow$451.7M+36.9%$426.0M+8.0%$527.3M+5.8%$420.0M-8.9%$329.8M-8.4%$394.5M+3.1%$498.3M+3.6%$460.9M+3.8%
Investing Cash Flow-$246.9M-722.7%-$234.6M-86.6%-$57.0M+67.5%-$850.0M-3172.6%-$30.0M-35.6%-$125.7M-487.1%-$175.3M+91.5%-$26.0M+85.3%
Financing Cash Flow-$220.1M-67.1%-$188.0M+32.3%-$509.7M-36.3%$232.7M+148.8%-$131.7M+60.6%-$277.7M+33.5%-$374.0M-135.2%-$476.8M-899.9%
Dividends Paid$77.9M+8.9%$77.8M+8.9%$71.0M+9.7%$71.4M+10.4%$71.5M+10.4%$71.5M+10.5%$64.7M+12.3%$64.7M+12.2%
Share Buybacks$165K+48.6%$27.9M+55.1%$270.4M+87.8%$145.5M+140.9%$111K-83.7%$18.0M+160.5%$144.0M+11963.0%$60.4M+111751.9%

AME Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AME quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross Margin35.9%+0.2pp37.2%+1.1pp36.0%-0.6pp36.3%+0.2pp35.8%-0.2pp36.1%+2.0pp36.6%+1.1pp36.0%-1.1pp
Operating Margin25.8%-0.1pp26.7%+0.4pp25.3%-1.3pp25.8%-0.3pp26.0%+0.2pp26.3%+2.2pp26.6%+0.9pp26.1%-0.9pp
Net Margin19.9%-0.3pp20.7%+0.4pp20.0%-2.0pp19.6%-0.3pp20.2%+0.7pp20.3%+2.4pp22.0%+2.2pp19.9%-1.1pp
Return on Equity3.6%+0.2pp3.7%+0.1pp3.8%-0.3pp3.5%0.0pp3.5%-0.2pp3.5%+0.1pp4.0%+0.1pp3.6%-0.5pp
Return on Assets2.5%+0.1pp2.5%+0.1pp2.5%-0.2pp2.3%0.0pp2.4%+0.1pp2.4%+0.3pp2.6%+0.4pp2.3%-0.3pp
Current Ratio1.21-0.4x1.14-0.3x1.06-0.2x1.16-0.2x1.63+0.4x1.41+0.3x1.24+0.3x1.39-0.5x
Debt-to-Equity0.09-0.1x0.100.0x0.100.0x0.140.0x0.150.0x0.15-0.1x0.15-0.1x0.180.0x
Asset Turnover0.120.0x0.120.0x0.120.0x0.120.0x0.120.0x0.120.0x0.120.0x0.120.0x
FCF Margin22.1%+3.5pp22.1%-0.7pp26.4%-1.9pp22.2%-4.8pp18.6%-2.2pp22.8%+0.7pp28.3%+0.5pp27.0%-0.4pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Ametek, Inc. AME FY2025 $7.4B $1.5B 20.0% $57.8B 69/100
Rockwell Automation, Inc. ROK FY2025 $8.3B $869.0M 10.4% $50.5B 58/100
Xylem Inc XYL FY2025 $9.0B $957.0M 10.6% $23.8B 68/100
Otis Worldwide Corporation OTIS FY2025 $14.4B $1.4B 9.6% $24.4B 53/100
Ingersoll Rand Inc. IR FY2025 $7.7B $581.4M 7.6% $29.5B 61/100
Illinois Tool Works Inc. ITW FY2025 $16.0B $3.1B 19.1% $74.9B 63/100

Frequently Asked Questions

What is Ametek, Inc.'s annual revenue?

Ametek, Inc. (AME) reported $7.4B in total revenue for fiscal year 2025. This represents a 6.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ametek, Inc.'s revenue growing?

Ametek, Inc. (AME) revenue grew by 6.6% year-over-year, from $6.9B to $7.4B in fiscal year 2025.

Is Ametek, Inc. profitable?

Yes, Ametek, Inc. (AME) reported a net income of $1.5B in fiscal year 2025, with a net profit margin of 20.0%.

Ametek, Inc. (AME) reported diluted earnings per share of $6.40 for fiscal year 2025. This represents a 7.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ametek, Inc. (AME) had EBITDA of $2.3B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Ametek, Inc. (AME) had $458.0M in cash and equivalents against $1.1B in long-term debt.

Ametek, Inc. (AME) had a gross margin of 36.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Ametek, Inc. (AME) had an operating margin of 25.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Ametek, Inc. (AME) had a net profit margin of 20.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Ametek, Inc. (AME) has a return on equity of 13.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Ametek, Inc. (AME) generated $1.7B in free cash flow during fiscal year 2025. This represents a -1.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Ametek, Inc. (AME) generated $1.8B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Ametek, Inc. (AME) had $16.1B in total assets as of fiscal year 2025, including both current and long-term assets.

Ametek, Inc. (AME) invested $130.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Ametek, Inc. (AME) invested $236.1M in research and development during fiscal year 2025.

Yes, Ametek, Inc. (AME) spent $434.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Ametek, Inc. (AME) had 229M shares outstanding as of fiscal year 2025.

Ametek, Inc. (AME) had a current ratio of 1.06 as of fiscal year 2025, which is considered adequate.

Ametek, Inc. (AME) had a debt-to-equity ratio of 0.10 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Ametek, Inc. (AME) had a return on assets of 9.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Ametek, Inc. (AME) trades at 36.6x earnings, its market capitalization divided by net income of $1.6B net income, trailing 12 months to June 30, 2026. The market capitalization is $57.8B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Ametek, Inc. (AME) trades at 7.3x sales, its market capitalization divided by revenue of $7.9B revenue, trailing 12 months to June 30, 2026. The market capitalization is $57.8B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Ametek, Inc. (AME) has an Altman Z-Score of 8.31, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Ametek, Inc. (AME) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Ametek, Inc. (AME) has an earnings quality ratio of 1.22x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Ametek, Inc. (AME) has an interest coverage ratio of 23.51x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Ametek, Inc. (AME) scores 69 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top